The 'Journal Scout'

I propose a partial reform of the existing scientific publishing process. My proposal aims to improve the techniques for manuscript processing and to stimulate competition among academic journals for exceptional articles. Despite its seeming widespread acceptance, the peer-review system is constantly under fire and criticism. Critics argue that it is excessively costly and time-consuming. The system is vulnerable to misconduct, plagiarism, and breach of confidentiality. Some of the most cited

Written byJuan Miguel Campanario
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

I propose a partial reform of the existing scientific publishing process. My proposal aims to improve the techniques for manuscript processing and to stimulate competition among academic journals for exceptional articles.

Despite its seeming widespread acceptance, the peer-review system is constantly under fire and criticism. Critics argue that it is excessively costly and time-consuming. The system is vulnerable to misconduct, plagiarism, and breach of confidentiality. Some of the most cited papers in the history of science, now widely accepted, were previously rejected by referees. At least eight articles that would eventually earn the Nobel Prize for their authors were initially rejected outright by reviewers (J.M. Campanario, Science Communication, 16:304-25, 1995). Although refereeing involves only a few hours, the whole process delays publication excessively. Indeed, the lag in some competitive fields is considered unacceptable (R. Roy, The Scientist, Sept. 6, 1993, page 11).

Under the current system, authors compete for space ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies